E172
P. Jain, S. Yi, and P. T. Flaherty
Vol 50
removed, and a 4.5 M aqueous solution of KHF2 (5.78 mL,
26mmol) was added at 0ꢀC. After addition, the mixture was
stirred at 0ꢀC for 1 h. The mixture was concentrated and
azeotroped with toluene three times at 60ꢀC on the rotavap to
remove residual water and dried under high vacuum overnight
to afford a white solid. The solid was broken into fine powder
with a spatula and then suspended in 10mL acetone on rotavap
with rotation at atmosphere pressure for 5 min at 40ꢀC. The
suspension was filtered through Celite. Acetone (5mL) was
added to the remaining solid in the flask and the procedure was
repeated two more times. The combined filtrates were
concentrated under vacuum. The solid obtained was dissolved in
minimum amount of hot acetone (4mL), and Et2O (5mL) was
added to precipitate a white solid. The mixture was slowly
cooled to room temperature, placed in ice bath for 1 h and in
refrigerator for another 2 h. The mixture was filtered, and the
white solid was collected and then dried under vacuum to afford
135.0 mg (14%) of the desired product 4e. 1H NMR (DMSO-
d6): d 6.89–6.90 (m, 2H), 6.62–6.64 (m, 2H), 3.65 (s, 3H), 1.37
(br, 2H).
1H NMR (400 MHz, CDCl3): d 8.08 (s, 1H), 7.79 (d, J = 2.32Hz,
1H), 7.23(d, J = 2.3 Hz, 1H), 4.68–4.75 (m, 1H), 3.95 (s, 3H),
2.35–2.30 (m, 2H), 1.83–2.05 (m, 6H). Anal. Calcd. for
C13H15N3O3: C, 59.76; H, 5.79; N, 16.08; O, 18.37. Found:
C,59.88; H, 5.84; N, 16.27.
1-Cyclopentyl-4-nitro-1H-benzo[d]imidazol-6-ol hydrobromide
(10).
A 50 mL microwave reactor tube was charged with 1-
(0.75 g,
cyclopentyl-6-methoxy-4-nitro-1H-benzo[d]imidazole
2.87 mmol) and 48% HBr (10 mL) and subjected to microwave
irradiation at 250 W to maintain a temperature of 120ꢀC
for 2.5 h. The solvent was removed in vacuo. The resultant
yellow solid was dissolved in a minimum amount of water.
Solid Na2CO3 was added in small portions until the pH was 6. The
mixture was filtered, and the yellow solid was collected then washed
with water and dried under high vacuum pump to afford 0.6 g
1
(85.7%) of 10. Rf 0.36 (CH2Cl2/MeOH/NH4OH 100 : 10 : 0.1). H
NMR (400 MHz, DMSO-d6): d 10.12 (s, 1H), 8.40 (s, 1H), 7.51
(d, J= 2.17 Hz, 1H), 7.38 (d, J= 2.21 Hz, 1H), 4.81–4.87 (m, 1H),
2.15–2.21 (m, 2H), 1.70–1.96 (m, 6H). Anal. Calcd. for
C12H13N3O3: 1.175. HBr: C, 42.09; H, 4.17; N, 12.27. Found: C,
42.13; H, 4.33; N, 12.12.
6-(4-Methoxy benzyl)-1-isopropyl-4-nitro-1H-benzo[d]imidazole
(5e). A dry microwave tube with a stir bar was charged with 1-
isopropyl-4-nitro-1H-benzo[d]imidazol-6-yl trifluoromethanesulfonate
(176.5 mg, 0.50 mmol), potassium (4-methoxybenzyl)trifluoroborate
(135.0mg, 0.60 mmol), Cs2CO3 (488.73 mg, 1.5mmol), and
PdCl2(dppf)•CH2Cl2 (40.83mg, 0.05 mmol). The microwave tube
was capped with a rubber septum and subjected to vacuum/N2
purge cycles three times. Degassed deionized water (0.5mL) and
THF (5mL) were added via syringe. The rubber septum was
quickly removed and replaced with the microwave tube cap, and
the mixture was subjected to microwave irradiation at 250 W to
maintain a temperature of 110ꢀC for 2.5 h. After cooling down to
room temperature, the mixture was filtered through Celite. The
filtrate was extracted with EA. The combined extracts were
washed with brine and dried over magnesium sulfate. Filtration
and then evaporation of the solvent gave a brown solid, which
was subjected to silica gel column chromatography (Hex/EA/TEA
1 : 1 : 0.005) to afford 80.0 mg of 5e (50%). Rf 0.4 (CH2Cl2/
1-Cyclopentyl-4-nitro-1H-benzo[d]imidazol-6-yl trifluoro-
methanesulfonate (8).
Solid K2CO3 (246.0 mg, 1.78 mmol)
was added to a solution of 1-cyclopentyl-4-nitro-1H-benzo[d]
imidazol-6-ol (220.0 mg, 0.89 mmol) and 4-nitrophenyl
trifluoromethanesulfonate (265.5 mg, 0.979 mmol) in 5mL of
DMF. The suspension was stirred at room temperature for 4 h.
Then the reaction mixture was diluted with EA (30 mL) and
filtered. The filtrate was washed with water (20mL Â 5) and brine
and then dried over Na2SO4. Filtration and evaporation of the
solvent gave a yellow oil, which was subjected to silica gel
column chromatography (Hex/EA/TEA 1 : 1 : 0.005) to afford
290.0 mg of triflate 8 (86%). Rf 0.5 (CH2Cl2/MeOH/NH4OH
100 : 5 : 0.1). mp 124–125ꢀC. 1H NMR (400 MHz, CDCl3): d 8.30
(s, 1H), 8.10 (d, J = 2.26 Hz, 1H), 7.74 (d, J = 2.27 Hz, 1H), 4.78–
4.83 (m, 1H), 2.42–2.36 (m, 2H), 1.91–2.05 (m, 6H). Anal. Calcd.
for C13H12F3N3O5S: C, 41.16; H, 3.19; F, 15.03; N, 11.08; O,
21.09; S, 8.45. Found: C, 41.21; H, 3.15; N, 11.08.
1
MeOH/NH4OH 100: 5 : 0.1). H NMR (CDCl3): d 8.16 (s, 1H),
6-Benzyl-1-cyclopentyl-4-nitro-1H-benzo[d]imidazole (11).
A
8.01 (d, J = 1.38 Hz, 1H), 7.50 (d, J = 1.36 Hz, 1H), 7.13 (d,
J = 8.74 Hz, 2H), 6.87 (d, J = 8.71 Hz, 2H), 4.63 (m, 1H), 4.14 (s,
2H), 1.63 (d, J = 6.75 Hz, 6H). HRMS (EI) Calcd. for
C18H19N3O3: 326.1499 [M+ H+]. Found 326.1500 [M+ H+],
348.1317 [M + Na+].
dry microwave tube with a stir bar was charged with 1-cyclopentyl-4-
nitro-1H-benzo[d]imidazol-6-yl trifluoromethanesulfonate (500.0 mg,
1.31 mmol), potassium benzyltrifluoroborate (259.41 mg, 1.31 mmol),
Cs2CO3 (640.23 mg, 1.965 mmol), and PdCl2(dppf)•CH2Cl2
(106.98 mg, 0.131 mmol). The microwave tube was capped with a
rubber septum and subjected to three vacuum/N2 purge cycles.
Degassed deionized water (0.8mL) and THF (8mL) were added
via syringe. The rubber septum was quickly replaced with the
microwave tube cap, and the mixture was subjected to
microwave irradiation at 250 W to maintain 110ꢀC for 1.8 h.
After cooling down to room temperature, the mixture was
filtered through Celite. The filtrate was extracted with EA. The
combined extracts were washed with brine and dried over
magnesium sulfate. Filtration then evaporation of the solvent
gave a brown solid, which was subjected to silica gel column
chromatography (Hex/EA/TEA 1 : 1 : 0.005) to afford 70.0mg of
the desired product (17%). Rf 0.45 (CH2Cl2/MeOH/NH4OH
1-Cyclopentyl-6-methoxy-4-nitro-1H-benzo[d]imidazole (9).
A
500 mL one-neck flask was charged with 5-methoxy-3-nitrobenzene-
1,2-diamine (3.67 g, 20.0 mmol), NaBH(OAc)3 (12.71 g, 60.0 mmol),
THF (60 mL), cyclopentanone (8.948 mL, 100.0 mmol), and formic
acid (2.26 mL, 60.0 mmol). The mixture was stirred overnight. The
solvent was removed in vacuo, and the dark red residue was
dissolved in formic acid (60 mL). Butylated hydroxytoluene
(20 mg) was added, and the mixture was cooled to 0ꢀC.
Concentrated HCl (80 mL) was added, and the mixture was
heated to reflux with a heating mantle. After maintaining reflux
for 25 min, most of the solvent was removed in vacuo at 80ꢀC.
The aqueous solution was neutralized with saturated potassium
carbonate solution to pH 8 and extracted with EA (50 mL Â 4).
The combined extracts were washed with brine and dried over
sodium sulfate. Evaporation of the solvent gave a brown solid,
which was subjected to silica gel column chromatography
(Hex/EA 1 : 1) to afford 2.1 g (40%) of 9 as a yellow solid (40%).
Rf 0.32 (CH2Cl2/MeOH/NH4OH 100 : 10 : 0.1). mp 107–108ꢀC.
1
100 : 5 : 0.1). mp 145–147ꢀC. H NMR (CDCl3): d 8.15 (s, 1H),
8.06 (d, J = 1.41Hz 1H), 7.55(d, J = 1.46Hz, 1H), 7.36 (m, 2H),
7.28 (m, 1H), 7.23 (dd, J = 1.41Hz, J = 8.1 Hz, 2H), 4.75
(m,1H), 4.22 (s, 2H), 2.29–2.36 (m, 2H), 1.85–2.02 (m, 6H).
Anal. Calcd. for C19H19N3O2: C, 71.01; H, 5.96; N, 13.08; O,
9.96. Found: C, 70.83; H, 5.88; N, 13.10.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet